Abstract:

In South Sudan there was cholera outbreak since 2014 affecting more than 14 counties. In response to the outbreak on June and July 2017, an oral cholera vaccination (OCV) campaign was conducted in Ayod County in four payams such as Jiech, Kandak, Karmuom and Padek. To assess the coverage of the vaccination, Post Campaign Evaluation survey was conducted in the above mentioned four payams. Cluster survey sampling methodology was used to determine sample size. From four targeted Payams in total 1,326(364 from Jiech, 350 from Kandak, 264 from Padek and 348 from Karmuom) respondents interviewed. The respondents categorized in to three age groups (1–4, 5–14, >15 years). The finding indicated different vaccination coverage in each Payams 86.1% (95% C.I 82.2%-89.9%) in Jiech, 81% (95% C.I 74.3%-87.9%) in Kandak, 88.6% (95% C.I 84.1%-93%) in Padek and 84.6% (95% C.I 79.9%-89.2%) in Karmuom. People who received two-doses of vaccination above 15 years of age were 84.3% (94% C.I 81.2%-87.5). The overall gender representativeness was marked by a big respondent of female compare to male respectively 536 and 464 with respective coverage of 53.6% (95% C.I 49.3-57.8) in female and 46.4% (95% C.I 41.8-50.9) in male. However, the complete two dose coverage was high in male 86.8 % (95% C.I 83.5-90.1) and female 84.3 (95% C.I 80.9-87.6). Kandak has the lowest coverage 81(74.3-87.9) of all payams. Based on the population structure and the target for reaching with oral cholera vaccination, the vaccination coverage is at the acceptable range to provide prevention and to interrupt transmission of infection.

References:

[1].  World Health Organization. (2010). Cholera Weekly Epidemiological Record. 2011; 86:325–39.

[2].  World Health Organization. (2011). Weekly Epidemiological Record. 2012; 87:289–304.

[3].  World Health Organization. (2012). Weekly Epidemiological Record. 2013; 88:321–34.

[4].  Republic of Haiti. National plan for the elimination of cholera in Haiti, 2013–2022: short term plan 2013–2015

[5].  World Health Organization. (May 2011). 64th World Health Assembly. Mechanism for Cholera control and prevention resolution.

[6].  Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, et al. (1999). Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.

[7].  Cavailler P, Lucas M, Perroud V, McChesney M, Ampuero S, Guerin PJ, et al. (2006). Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique.

[8].  Schaetti C, Ali SM, Chai gnat C-L, Khatib AM, Hutubessy R, Weiss MG. (2012). Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.

[9].  Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, et al. (2013). Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.

[10].  Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, et al. (2013). Use of oral cholera vaccine in Haiti: a rural demonstration project.

[11].  Rouzier V, Severe K, Jean Juste MA, Peck M, Perodin C, Severe P, et al. (2013). Cholera vaccination in urban Haiti.

[12].  Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, et al. (2014). Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.

[13].  World Health Organization. (2014). Oral cholera vaccine campaign among internally displaced persons in South Sudan. Weekly Epidemiological Record. 2014; 89:214–20.

[14].  Calain P, Chaine J-P, Johnson E, Hawley M-L, O’Leary MJ, Oshitani H, et al. (2004). Can oral cholera vaccination play a role in controlling a cholera outbreak?

[15].  Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, Park JK, et al. (2011). Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

[16].  Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. (2012). First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea.

[17].  Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. (2014). Use of Vibrio cholerae vaccine in an outbreak in Guinea.

[18].  South Sudan Health Cluster Bulletin number 6, WHO 30th June 2017.